What You Need to Know to Participate
This document provides information to help you decide whether to join this research study. It is important you understand the responsibilities, risks and benefits of participating.
Summary Information to Help you Decide Whether to Join this Study
Study Title | Daily Creatine Intake for Muscle Growth |
---|---|
Study Author | Ilya Pantsyr |
Sponsor | This study is made possible by your payment to join. |
Cost of Products, Services & Information to Participant | $0 |
Included Products & Services | Test Product Creatine |
Outcome Measures | |
Contact | help@efforia.com |
Introduction & Summary
Welcome to the research study on the Efforia platform! This study is made possible by your participation and support. The purpose of this document is to help you understand the study and decide whether you want to take part. Your participation is entirely voluntary, and you can leave the study at any time without any penalties. If you have any questions or concerns, please reach out before you join the study.
Purpose of the Study
This study aims to investigate the effects of daily creatine intake on muscle growth. Creatine is a popular supplement often used to enhance athletic performance and increase muscle mass. By participating, you will contribute to scientific knowledge that could benefit society by providing insights into the efficacy of creatine for muscle growth.
What You Will Do as Part of this Study
While participating in this research study, you will need to:
- Be willing and able to follow the study directions and procedures
- Tell Efforia about any side effects or problems by communicating with help@efforia.com or online chat.
- Ask questions as you think of them, via help@efforia.com or online chat.
- Inform Efforia if you change your mind about staying in the study. You may leave the study at any time by communicating with help@efforia.com or chat.
Participant Responsibilities and Tasks
Participants in the study are expected to adhere to a strict schedule and follow the outlined protocol meticulously. The overall schedule includes a series of treatment activities along with subsequent measurements to ensure the accuracy and integrity of the study. Below is a detailed summary of the key responsibilities and tasks:
Overall Schedule and Specific Timeline
The study is structured across multiple phases, each with specific timelines for completion. Participants will be informed of the exact dates and deadlines, and it is crucial to adhere to these to maintain the study's validity.
Treatment Activities
Participants are required to take a creatine supplement as part of the treatment activities. Detailed instructions on dosage and frequency will be provided. Consistency in taking the supplement is essential for the success of the study.
Frequency of Activities and Measurements
Treatment activities, including taking the creatine supplement, will be conducted daily. Participants will also undergo regular measurements to monitor progress and effects, with a specific schedule to be provided. Adhering to this schedule is critical to ensure accurate and reliable data collection.
It is imperative that participants follow the timeline and instructions precisely to contribute to the study's success and the validity of the results.
The Risks, Discomforts & Benefits of Being in this Study
There are some unique risks, discomforts, and potential benefits of being in this study that you should understand.
Consider your Own Risk-Benefit Comfort Level
It is possible that not all risks and benefits are currently known. Participants have the responsibility to consult with their healthcare providers and conduct further research before enrolling in the study.
Personal and Overall Findings
Efforia will provide you with both personal outcomes as well as overall findings. These findings will be made available at various data collection points in your experience in the study or as they are discovered by Efforia. The results and findings may impact your interest and willingness to be involved in the study. Remember, participation is voluntary and you may exit at any time by sending an email to help@efforia.com.
Possible Benefits of Participation
Possible benefits include gaining insights into the effects of creatine on muscle growth, contributing to scientific knowledge, and potentially enhancing your own muscle growth. However, there is a possibility that there will be no measurable benefit to you, other than seeing reports that the intervention or treatment had no measurable impact.
Possible Serious Adverse Events & Side Effects
Introduction and Summary of Known Risks
The following document provides a detailed analysis of the known risks associated with the use of Test Product Creatine, a supplement commonly utilized to enhance physical performance and muscle growth. Creatine is widely researched, with numerous studies indicating both its efficacy and potential side effects.
The following is a summary of known risks. However, research is limited, and there may be risks not covered by this document, risks that are currently unknown or unforeseen. Please consider these risks carefully, do your own that research, and talk to a professional who knows you well and has expertise in this area, like your personal physician.
Generally, the recommended dosage for creatine supplementation is 5 grams per day, with some protocols suggesting a loading phase of 20 grams per day, divided into 4 servings, for 5-7 days, followed by a maintenance phase. Side effects often become more pronounced at dosages exceeding these recommendations.
In the Case of an Adverse Event
If you experience any severe reactions such as difficulty breathing, severe allergic reactions, or any symptoms causing major discomfort, immediately call 911 to seek emergency medical assistance. After addressing any acute issues, please contact Efforia to report the incident.
Serious Adverse Events (SAEs)
Potential Serious Adverse Events associated with Test Product Creatine could include, but are not limited to:
Theoretical side effects | Relative incidence | Recovery |
---|---|---|
Kidney damage in those with pre-existing conditions | Very low likelihood | Corrects after discontinuation if no permanent damage |
Electrolyte imbalances due to excessive water retention | Low likelihood | Corrects after discontinuation |
Dehydration and muscle cramps | Moderate likelihood | Corrects after discontinuation |
Frustration and irritation | Moderate likelihood | Subsides with use |
Common Risks and Side Effects
Risks associated with Test Product Creatine usage may include:
- Gastrointestinal Symptoms: Some users report stomach pain, diarrhea, and nausea. These effects are generally mild and often subside with continued use.
- Weight Gain: Due to water retention in the muscles, rapid weight gain can occur, which is typically temporary.
- Muscle Cramping: Likely due to dehydration and electrolyte imbalances, muscle cramps can occur, especially when not consuming sufficient fluids.
- Renal Stress: In individuals with pre-existing kidney conditions, high doses of creatine may exacerbate renal function.
Efforia's Limitations in Providing Direct Medical Support
Efforia is not equipped to provide direct medical interventions or emergency medical support. In the event of an adverse reaction, users are advised to seek immediate medical care from healthcare providers.
Dependency and Long-Term Use
No known dependency has been associated with creatine use. However, users should consider cycling off creatine for a period after prolonged use to assess tolerance and potential effects of discontinuation.
Legality and Compliance
Creatine is legal and is not classified as a banned substance by major sports organizations including the World Anti-Doping Association and the National Collegiate Athletic Association. It is generally accepted in corporate workplaces unless specific health conditions are being monitored that could be exacerbated by its use.
By considering the comprehensive data and potential risks outlined above, users and practitioners can make informed decisions regarding the use of Test Product Creatine.
Privacy & Security Risks
We are doing everything we can think of to keep your data private and confidential. However, there is no such thing as no risk. Potential participants should review the Efforia general privacy policy, which is available here: https://efforia.com/privacy-policy/
There may be very certain limits to the rights of your privacy:
- We may reach out to local help if we have reason to believe you may be a harm to yourself and/or others.
- Regulators, like the FDA or similar agency, or Institutional Review boards may review records that have your identifying information.
What to do if you have a study related injury
Seek local medical care first, if necessary. Efforia cannot provide emergency medical care or diagnosis. However, it is important to contact Efforia if you experience any problems, have any side effects, or have any study-related injury after you've received any necessary treatment. We want to make sure others are aware of potential risks.
Study related injury care and compensation
Efforia is not able to offer financial compensation nor to absorb the costs of medical treatment should you be injured as a result of participating in this research. Efforia makes no commitment to provide free medical care or payment for any unfavorable outcomes resulting from participation in this research.
In the case of medical emergency
In the case of medical emergency please dial 911 immediately. Do not attempt to contact Efforia until after the emergency has passed. Access local in-person medical assistance immediately. If at any time you feel like you may be a danger to yourself or others, please dial 988 for the National Suicide Prevention hotline. Help is available.
Alternatives to Participating in the Study
Since this study is for research only, the only other choice would be not to be in the study. If this study does not seem quite right or is too expensive for your specific purposes, Efforia is dedicated to making other studies available. You may click on the Efforia logo in the upper portion of the page and find a different study that may be more appropriate.
Your Rights as a Participant
Efforia upholds the same high ethical standards in research as seen in pharmaceutical and academic studies, despite only hosting and not sponsoring or conducting these studies. Your participation in this study is completely voluntary, and you are free to withdraw at any time without any adverse consequences. You are not giving up any rights by signing this document.
Privacy and Confidentiality
You have a right to privacy and confidentiality in this research effort. Your personal information is protected through robust measures ensuring anonymity or confidentiality. All data processing is designed to safeguard personal data against unauthorized access and misuse.
Right to Your Own Results
Participants have the right to a complete explanation of the research once their involvement concludes, particularly if the study involves any form of deception like placebos or controls.
The Right to Leave a Study without Penalty at Any time
If you decide to withdraw from the study, you can do so at any time by visiting your Profile page, selecting "Your Protocols," and clicking "Leave." Upon leaving, you will be refunded for any consumable products that have not yet been shipped. For non-consumable products, a full refund will be issued upon their return in accordance with our return policy. This ensures that you can participate in the study with the assurance that your financial contributions are handled fairly and with respect for your consumer rights.
Conflict of Interest Statement
As part of our commitment to ethical conduct and transparency in our citizen science clinical trial, it is essential to disclose the unique structure of our study. This clinical trial is hosted by Efforia, but it is uniquely sponsored by you, the participants. Efforia serves solely as the platform provider and does not sponsor or influence the study outcomes.
Efforia takes a transaction fee on all the products and services included in this protocol. Otherwise, we have no financial interest or conflicts of interest. To further reduce conflicts of interest, we will remind you once if you do not complete enrollment in this study. We will not remarket to you, nor otherwise push you to join the study.
How we Reduce Conflicts of Interest
Participants have a role in reducing conflicts of interest as well. It is crucial that participants do not have any financial relationship with the intervention methods or measurement providers used in the trial, nor should they be employees, investors, stakeholders, or protocol authors associated with these entities. Participation under such conflicts of interest could significantly compromise the study's integrity and the validity of its results.
Consequences of Conflict of Interest Non-Compliance
Should a participant fail to disclose such a conflict of interest or if a breach of this policy is discovered, the participant will be subject to immediate suspension from this platform and payments may not be refunded.
By joining this trial, you affirm that you understand the above conflict of interest restrictions and agree to comply fully with them. Your participation is valued, and your adherence to these guidelines ensures the validity and reliability of our collective scientific efforts.
Data Protections
Describe how data will be collected, used, and protected, ensuring compliance with data protection laws.
What you can do to improve your privacy and security
As part of participating in this study, you will receive notifications via e-mail, SMS, or push notification when new study tasks like questionnaires and reminders are ready for you. You can adjust your communication preferences in the Efforia application at any time. If you do not want to receive notifications from this study, do not press the Accept button. You can decide not to join this study, and will not receive notifications. To ensure others don’t see these alerts, you should make sure your phone or desktop computer and your e-mail accounts are protected by a password, pin, or other form of “access control.” You should also avoid sharing your accounts with others or sharing your account passwords. As this study is hosted in Efforia, it is governed by a set of privacy and confidentiality standards that put you, as a participant, in control. You can learn more about Your Privacy and Security rights on Efforia here: https://efforia.com/privacy-policy/.
Who will have access to your data?
Efforia will have access to your data. Additionally, there may be partners who also have access to your data, such as labs and connected health devices.
What will we do with your data?
We will use the data to show you your own personal results, and pool your results with other participants to provide general outcomes. We will not use your information connected with your name or anything that connects the data with you without your permission.
California Experiential Research Subject’s Bill of Rights
Participants have the right to be informed of the California Experiential Research Subject Bill of Rights. You can learn more about Your Privacy and Security rights on Efforia here: https://efforia.com/privacy-policy/.
Who to Contact for Questions or Concerns
If you have questions, concerns, or complaints about this study or to report a study related injury, contact:
HELP@EFFORIA.COM
OR CLICK THE CHAT BUTTON ON YOUR SCREEN
If you are unable to reach anyone at the number(s) listed above and you require immediate (life threatening) medical attention, please go to the nearest emergency room.
If you do not want to talk to the investigator or study staff, if you have concerns or complaints about the research, or to ask questions about your rights as a study subject you may contact IntegReview. IntegReview is a group of people that have reviewed this research study. The main goal of this review is to protect the rights and well-being of the human subjects participating in research studies. IntegReview’s policy indicates that all concerns/complaints are to be submitted in writing for review at a convened IRB meeting to:
Chairperson
BRANY
123 Main Street
Suite 320
NY, NY 78704
email@BRANY.com
If you are unable to provide your concerns/complaints in writing or if this is an emergency situation regarding subject safety, contact our office at:
555-326-3001 or
toll free at 1-800-123-4567
between 8 a.m. and 5 p.m. Eastern Standard Time
Additional questions and closing
Efforia and BRANY have approved the information in this consent form and has given approval to public this study. This does not mean Efforia or BRANY have approved your being in the study. You must consider the information in this consent form for yourself and decide if you want to be in this study.
If you have questions please contact help@efforia.com. Also, please note it is up to you to do additional research and talk to your physician before joining a study.